PERSPECTIVES NOUVELLES DANS LE DOMAINE DU BLOCAGE DES RECEPTEURS ADRENERGIQUES CARDIAQUESSHANKS RG.1973; REV. MED.; FR.; DA. 1973; VOL. 14; NO 5; PP. 345-354 (8P.); ABS. ANGL.; BIBL. 22REF.Serial Issue

EFFECTS OF TIPRENOLOL, PRACTOLOL AND PROPRANOLOL ON EXPERIMENTAL VENTRICULAR TACHYARRHYTHMIAS = EFFETS DU TIPRENOLOL, DU PRACTOLOL ET DU PROPRANOLOL SUR LES TACHYARYTHMIES VENTRICULAIRES EXPERIMENTALESALLEN JD; SHANKS RG.1974; BRIT. J. PHARMACOL.; G.B.; DA. 1974; VOL. 51; NO 2; PP. 179-185; BIBL. 1P.Article

EVALUATION OF ONCE DAILY SOTALOL ADMINISTRATION IN MAN.MCDEVITT DG; SHANKS RG.1977; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1977; VOL. 4; NO 2; PP. 153-156; BIBL. 5 REF.Article

METABOLIC AND CARDIOVASCULAR EFFECTS OF ISOPRENALINE AND SALBUTAMOL IN THE DOG = EFFETS METABOLIQUES ET CARDIOVASCULAIRES DE L'ISOPRENALINE ET DU SALBUTAMOL CHEZ LE CHIENKELLY JG; SHANKS RG.1975; BRIT. J. PHARMACOL.; G.B.; DA. 1975; VOL. 53; NO 2; PP. 157-162; BIBL. 12 REF.Article

ALINIDINE BIOTRANSFORMATION IN HEALTHY SUDANESE ARABSHARRON DWG; ARNDTS DE; SHANKS RG et al.1982; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1982; VOL. 12; NO 4; PP. 277-283; BIBL. 8 REF.Article

CARDIOVASCULAR EFFECTS OF ALINIDINE AND PROPRANOLOL ALONE AND IN COMBINATION WITH HYDRALAZINE IN NORMAL MANNICHOLLS DP; HARRON DWG; SHANKS RG et al.1983; BRITISH JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0306-5251; GBR; DA. 1983; VOL. 15; NO 1; PP. 21-29; BIBL. 26 REF.Article

ALINIDINE REDUCES HEART-RATE WITHOUT BLOCKADE OF BETA-ADRENOCEPTORSHARRON DW; RIDDELL JG; SHANKS RG et al.1981; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1981; NO 8216; PP. 351-353; BIBL. 11 REF.Article

CARDIOVASCULAR EFFECTS OF INDORAMIN IN MAN: A DOSE RANGING STUDYNICHOLLS DP; HARRON DWG; SHANKS RG et al.1983; BRITISH JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0306-5251; GBR; DA. 1983; VOL. 15; NO 1; PP. 31-36; BIBL. 2 P.Article

CARDIOVASCULAR EFFECTS OF ALINIDINE (ST567) IN HEALTHY VOLUNTEERSHARRON DWG; RIDDELL JG; SHANKS RG et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 1; PP. 116P-117P; BIBL. 2 REF.Article

ANTI-ARRHYTHMIC DRUGSCARSON IW; LYONS SM; SHANKS RG et al.1979; BRIT. J. ANAESTH.; GBR; DA. 1979; VOL. 51; NO 7; PP. 659-670; BIBL. 3 P.Article

INTRINSIC HEART RATE ON EXERCISE AND THE MEASUREMENT OF BETA -ADRENOCEPTOR BLOCKADE.CARRUTHERS SG; SHANKS RG; MCDEVITT DG et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; PP. 991-999; BIBL. 13 REF.Article

THE CLINICAL PHARMACOLOGY OF BETA ADRENERGIC BLOCKING DRUGS.MCDEVITT DG; SHANKS RG; PRICHARD BNC et al.1976; J.R. COLL. PHYSICIANS LONDON; G.B.; DA. 1976; VOL. 11; NO 1; PP. 21-34; BIBL. 2 P. 1/2Article

A COMPARISON OF PLASMA LEVELS OF THEOPHYLLINATES AFTER ORAL ADMINISTRATION = COMPARAISON DES TAUX PLASMATIQUES DES THEOPHYLLINATES APRES L'ADMINISTRATION PER OSSIMS BA; KELLY JG; SHANKS RG et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 1; PP. 194-196; BIBL. 5 REF.Article

ALINIDINE PHARMACOKINETICS FOLLOWING ACUTE AND CHRONIC DOSINGHARRON DWG; ARNDTS D; SHANKS RG et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 6; PP. 821-827; BIBL. 9 REF.Article

DEBENDOX AND CONGENITAL MALFORMATIONS IN NORTHERN IRELANDHARRON DWG; GRIFFITHS K; SHANKS RG et al.1980; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1980; VOL. 281; NO 6252; PP. 1379-1381; BIBL. 10 REF.Article

NEONATAL THYROTOXICOSIS TREATED WITH PROPANOLOL = THYREOTOXICOSE NEONATALE TRAITEE PAR LE PROPRANOLOLPEMBERTON PJ; MCCONNELL B; SHANKS RG et al.1974; ARCH. DIS. CHILDH.; G.B.; DA. 1974; VOL. 49; NO 10; PP. 813-815; BIBL. 9REF.Article

CHANGES IN HEART RATE AND FOREARM BLOOD FLOW FOLLOWING INTRAVENOUS BOLUSES OF ISOPRENALINE IN THE PRESENCE OF PRACTOLOL AND PROPRANOLOLARNOLD JMO; ALLEN JA; SHANKS RG et al.1983; BRITISH JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0306-5251; GBR; DA. 1983; VOL. 15; NO 1; PP. 37-40; BIBL. 10 REF.Article

COMPARISON OF THE ACTIVITY AND PLASMA LEVELS OF OXOPRENOLOL, SLOW RELEASE OXOPRENOLOL, LONG ACTING PROPRANOLOL AND SOTALOLLEAHEY WJ; NEILL JD; VARMA PMS et al.1980; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1980; VOL. 17; NO 6; PP. 419-424; BIBL. 13 REF.Article

COMPARISON OF THE BETA -ADRENOCEPTOR BLOCKING ACTIVITY OF OXPRENOLOL, SLOW RELEASE OXPRENOLOL AND A COMBINED OXPRENOLOL DIURETIC PREPARATIONKERR MJ; HARRON DWG; KINNEY C et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 6; PP. 869-871; BIBL. 12 REF.Article

COMPARISON OF THE EFFICACY AND PHARMACOKINETICS OF CONVENTIONAL PROPRANOLOL AND A LONG ACTING PREPARATION OF PROPRANOLOLLEAHEY WJ; NEILL JD; VARMA MPS et al.1980; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1980; VOL. 9; NO 1; PP. 33-40; BIBL. 17 REF.Article

EFFECT OF ALINIDINE ON EXPERIMENTAL CARDIAC ARRHYTHMIASHARRON DWG; ALLEN JD; WILSON R et al.1982; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1982; VOL. 4; NO 2; PP. 221-225; BIBL. 27 REF.Article

MEXILETINE IN NORMAL VOLUNTEERSCAMBELL NPS; KELLY JG; ADGEY AAJ et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 4; PP. 372-373; BIBL. 5 REF.Article

THE CLINICAL PHARMACOLOGY OF MEXILETINECAMPBELL NPS; KELLY JG; ADGEY AAJ et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 2; PP. 103-108; BIBL. 12 REF.Article

THE EFFECT OF KOE 1173, A NEW ANTICONVULSANT AGENT ON EXPERIMENTAL CARDIAC ARRHYTHMIAS = L'EFFET DU KOE 1173, UN NOUVEL AGENT ANTICONVULSIVANT SUR LES ARYTHMIES CARDIAQUES EXPERIMENTALESALLEN JD; KOFI EKUE JM; SHANKS RG et al.1972; BRIT. J. PHARMACOL.; G.B.; DA. 1972; VOL. 45; NO 4; PP. 561-573; BIBL. 11 REF.Serial Issue

COMPARATIVE PHARMACOLOGICAL AND PHARMACOKINETIC OBSERVATIONS ON PROPRANOLOL (LONG ACTING FORMULATION) AND BENDROFLUAZIDE ADMINISTERED SEPARATELY AND CONCURRENTLY TO VOLUNTEERSNICHOLLS DP; HARRON DWG; MCAINSH J et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 5; PP. 727-732; BIBL. 20 REF.Article